Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study

Autor: Adam Balogh, Péter Antal-Szalmás, Zoltan Pap, Edit Kalina, Harjit Pal Bhattoa, Eva Kulcsar-Jakab, Z. Pethö, Roza Foldesi
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Zdroj: BMC Musculoskeletal Disorders
ISSN: 1471-2474
Popis: Background The aim of the present study is to evaluate serum osteoprotegerin (OPG) and soluble receptor activator of nuclear factor κB ligand (sRANKL) levels in a randomly selected male cohort over 50 years of age and its association with cystatin C, a cysteine proteinase inhibitor that decreases formation of osteoclasts by interfering at a late stage of pre-osteoclast differentiation, apart from being a marker of renal function independent of gender, muscle mass and age; in addition to known predictors such as age, sex hormones, vitamin D, bone mineral density (BMD) and biochemical markers of bone turnover. Methods We determined serum OPG and sRANKL levels and examined its relationship with cystatin C, age, osteocalcin, C-terminal telopeptides of type-I collagen, procollagen type 1 amino-terminal propeptide, 25-hydroxyvitamin D, parathyroid hormone, total 17β-estradiol (E2), total testosterone and L1–L4 (LS) and femur neck (FN) BMD data available from 194 (age, range: 51–81 years) randomly selected ambulatory men belonging to the HunMen cohort. Results OPG correlated significantly with age (Spearman’s rho (r) = 0.359, p 59 years, n = 96) had significantly higher serum OPG (4.6 pmol/L vs. 5.4 pmol/L; p
Databáze: OpenAIRE